Update
$Tharimmune (THAR.US)$ Reuters· 3 mins ago
Tharimmune Acquires Global License & Partners With Intract Pharma to Develop Oral Formulation of Infliximab
Tharimmune Acquires Global License & Partners With Intract Pharma to Develop Oral Formulation of Infliximab
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
EUGENE啊梁 : Is it taking off?
Trytosaveabit OP EUGENE啊梁 : Don’t know yet? Watching still
potsy52 : Waiting till market opens?
Trytosaveabit OP potsy52 : I’ll say I’m still watching!